Navigation Links
Golden Meditech Announces Interim Results of FY2009/10
Date:12/17/2009

HONG KONG, Dec. 17 /PRNewswire-Asia/ -- China's leading high-tech healthcare group, Golden Meditech Company Limited ("Golden Meditech" or "the Group"; Stock Code: 801) is pleased to announce today the interim results for Financial Year 2009/10. During the period under review, the Group's two associate companies made their debut on the New York Stock Exchange and NASDAQ; its key businesses have been strengthened, with maiden revenue and profit contributions from its new hospital management operations.

Mr. KAM Yuen, Chairman and CEO of Golden Meditech, emphasized that the two associate companies, China Cord Blood Corporation (NYSE: CO) and FunTalk China Holdings Limited (Nasdaq: FTLK), are recognized leaders in their fields with leading market shares. Their listings in the U.S. will not only attract investor interest in these companies, but also unlock shareholder value and generate significant returns for our shareholders.

Based on their offering prices, Golden Meditech's holding of these two firms is valued at US$281 million.

Mr. KAM explained that the Group decided to spin off these two entities to fulfill a commitment to shareholders. "These are also vivid examples of our successful investments and expansion strategies in the China market," said Mr. KAM.

During the first half of this year, the Group's medical device segment promoted its two new products in China. Meanwhile, it also reached an agreement to partner with Fenwal Inc., a global leader of blood transfusion technology, to jointly explore business opportunities in China's blood collection and transfusion market.

At the same time, the Group pushed ahead to develop its hospital management businesses in order to capture the lucrative business opportunities arising from China's ongoing medical reform. The expansion into the key healthcare value chain is well in alignment with the Group's core competencies and resources. The Group recorded HK$16,699,000 of revenue and posted strong profits from its hospital management operations for the second quarter of this financial year.

In addition, the hospital management operations raised US$28 million (equivalent to HK$217 million) in private equity financing in October 2009, valuing the entire business at more than US$ 200 million. The money raised will be used for business development in the China hospital market.

The group reported total turnover of HK$131,593,000 in the first half of this financial year. Its gross profit margin was maintained at about 67.4%.

About Golden Meditech:

Golden Meditech was listed on the Stock Exchange of Hong Kong Limited (HKEX) in December 2001, as the first hi-tech medical device enterprise to go public outside of the PRC. Thanks to its great efforts in innovation and market expansion, as well as its first-mover abilities in capturing emerging market opportunities, Golden Meditech's medical devices, cord blood banking services and innovative natural herbal medicines have all established dominant positions in their own sectors over the past years. Going forward, Golden Meditech will continue its strategy of becoming China's leading integrated medical group through organic growth, acquisitions and strategic investments.

    For further information, please contact:

    Golden Meditech Company Limited
     Investor Relations Division
     Add:   48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong
     Tel:   +852-3605-8138
     Fax:   +852-3605-8181
     Email: ir@goldenmeditech.com

SOURCE Golden Meditech Company Limited


'/>"/>
SOURCE Golden Meditech Company Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection
2. Frost & Sullivan to Hold Analyst Briefing on the European Neurophysiological Monitoring Market, the Golden Standard in Patient Safety
3. Axium Healthcare Pharmacy, Inc. Has Been Chosen as One of Central Floridas Golden 100 Companies for the Fifth Year in a Row
4. GoldenAgeMedical.Com Announces National TV Campaign
5. Golden Meditech Announces Financial Year 2008/09 Annual Results
6. Golden Rainbow Celebrates Las Vegas Entertainment in 23rd Annual Ribbon of Life Production Show
7. WWII Veterans Compete in National Veterans Golden Age Games
8. Golden rice an effective source of vitamin A
9. Thermal Angel Supports Infection Control During the Golden Hour
10. IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting
11. Golden Meditech Releases FY2008/09 Q3 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
Breaking Medicine Technology: